The global Custom Antibody Market is valued at USD 553.05 Million in 2024 and is projected to reach a value of USD 1237.1 ...

The anti-GPC3 targeted therapies market is expected to witness growth in the coming years, driven by the increasing incidence of cancer cases, clinical pipeline activity, and anticipated regulatory ...

In a bold move that could reshape the future of biomedical research, Boster Bio is launching a Free Antibody Validation ...

Sigvotatug Vedotin is an ADC that targets integrin αvβ6-positive tumor cells. It has an engineered antibody that ensures high ...

These properties make SA invaluable in biomolecule capture and enrichment in analytical applications such as ELISA, protein ...

Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that it has ...

The increasing demand for donor hearts presents both a critical challenge and a significant opportunity for innovation in ...

While AI-driven approaches tout increased speed and lower costs, commercial interests compromise scientific collaboration.

Creative Biolabs has a professional platform that provides customized CAR construction and design, meeting diverse needs of CAR-T cell therapy resear ...